[Dry mouth] [0.03%]
[口干]
Michael Reiss,Gilfe Reiss
Michael Reiss
Dryness of the mouth (xerostomia) is a serious problem for the affected patients, in particular if it is caused by a reduced salivation. Triggering factors are, e.g., drugs (antihypertensives, neuroleptics), CNS disorders, chronic obstructi...
Thomas Herdegen,Joachim Fauler
Thomas Herdegen
In this review the risk-benefit ratio of COX-2 inhibitors and NSAIDs is compared. In the discussion of the safety of these two groups different evaluation standards are used, which is not a basis of a rational pharmacotherapy.
[Prevention of cardiovascular diseases with omega-3-fatty acids and vitamins?] [0.03%]
[ω-3脂肪酸和维生素防治心血管疾病?]
Annemarie Musch
Annemarie Musch
Ralf Lobmann
Ralf Lobmann
Werner Menz
Werner Menz
[Dipeptidylpeptidase IV inhibitors and dual action PPAR-agonists] [0.03%]
二肽基肽酶Ⅳ抑制剂与双效过氧化物酶体增殖激活受体激动剂
Susanne Heinzl
Susanne Heinzl
Bericht von Susanne Heinzl
Bericht von Susanne Heinzl
[Exenatide--an incretin mimetic for treatment of diabetes mellitus type 2] [0.03%]
艾塞那肽——一种治疗二型糖尿病的胰高血糖素样肽-1(GLP-1)类似物类药物
Annemarie Musch,Susanne Heinzl
Annemarie Musch
Susanne Heinzl
Susanne Heinzl